Analystreport

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $21.00 price target on the stock.

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share  (AVDL) 
Last avadel pharmaceuticals plc - american depositary shares each representing one ordinary share earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: avadel.com